Profilo
Attualmente, Klaus Henning Jensen è Chief Medical Officer di Vifor Pharma AG. In passato il Dr. Jensen ha occupato la posizione di responsabile dell'area terapeutica e dello sviluppo del diabete presso Sanofi. Il Dr. Jensen ha ricevuto un dottorato dall'Università di Copenhagen e un MBA dalla Copenhagen Business School.
Precedenti posizioni note di Klaus Jensen
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 01/12/2019 |
| NOVO NORDISK A/S | General Counsel | - |
| VIFOR PHARMA | Chief Tech/Sci/R&D Officer | - |
Formazione di Klaus Jensen
| Copenhagen Business School | Masters Business Admin |
| University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| SANOFI | Health Technology |
| Aziende private | 1 |
|---|---|
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Klaus Jensen
